FDA gives Moderna's COVID vaccine emergency use authorization

 

• Moderna (NASDAQ:MRNA) gets emergency use authorization of mRNA-1273, its vaccine against COVID-19, from the U.S. Food and Drug Administration, making it the second vaccine to gain EUA in an effort to stem the pandemic.
• Delivery of the vaccine to the U.S. government will begin immediately; ~20M doses will be delivered by the end of December.
• The U.S. government has ordered a total of 200M doses of the Moderna vaccine to date and has an option to buy up to an additional 300M doses.
• Moderna will continue to gather additional data and plans to file a Biologics License Application with the FDA requesting full licensure in 2021.
• Earlier today, Moderna announced that the European Commission exercised its option to buy an additional 80M doses of the vaccine, bringing its total order commitment to 160M doses.
• https://seekingalpha.com/news/3646013-u-s-fda-gives-modernas-covid-vaccine-emergency-use-authorization